Kei Ishibashi - Concepedia

Author

Kei Ishibashi

Fukushima Medical University ORCID

Also Known As

Ishibashi Kei, Ishibashi, Kei, K Ishibashi, K. Ishibashi, KEI ISHIBASHI, Kei ISHIBASHI, Kei Ishibashi, Yuichi Sato

184

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Fukushima Medical University Asahikawa Medical University Asahikawa Medical College Hospital Augusta University Health National Institute of Infectious Diseases

About

Kei Ishibashi is an author at Fukushima Medical University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	778
2	Cell Biology	4	4	145
3	Health Sciences	2	2	64
4	Public Health	1	1	11
5	Biostatistics	1	1	11

Kei Ishibashi

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site Takayuki Ohkuri, Akemi Kosaka, Kei Ishibashi, Cancer Immunology Immunotherapy InflammationIntratumoral AdministrationCytokineCancer ImmunosurveillanceMedicine	2017	202
Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy Toshihiro Nagato, Takayuki Ohkuri, Kenzo Ohara, Cancer Immunology Immunotherapy Lymphoid NeoplasiaAutoimmune DiseaseSoluble FormImmunologyTumor Immunity	2017	158
Etiology of Severe Sensorineural Hearing Loss in Children: Independent Impact of Congenital Cytomegalovirus Infection and<i>GJB2</i>Mutations Hiroshi Ogawa, Tatsuo Suzutani, Yohko Baba, The Journal of Infectious Diseases	2007	121
Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade Kei Ishibashi, Tobias Haber, Ines Breuksch, Oncotarget	2017	55
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes Akemi Kosaka, Kei Ishibashi, Toshihiro Nagato, The Journal of Experimental Medicine ImmunologyImmune RegulationImmunoeditingImmunologic MechanismIntratumoral Sting-targeting Therapy	2021	51
Differential Mutation Patterns in Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus Type 1 Clones Passaged in the Presence of Acyclovir or Penciclovir Tatsuo Suzutani, Ken Ishioka, Erik De Clercq, Antimicrobial Agents and Chemotherapy	2003	48
c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma Takumi Kumai, Yoshinari Matsuda, Takayuki Ohkuri, OncoImmunology	2015	47
Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression Toshiki Oguro, Kei Ishibashi, Takashi Sugino, European Journal of Cancer CytokineAutoimmune DiseaseAntihuman Il-6r AntibodySocs3 ExpressionImmunology	2012	47
RSV replication is attenuated by counteracting expression of the suppressor of cytokine signaling (SOCS) molecules Koichi Hashimoto, Kei Ishibashi, Ken Ishioka, Virology CytokineViral ReplicationSignal TransductionAdaptive Immune SystemCytokine Signaling	2009	46
IgG4-related lung disease showing high standardized uptake values on FDG-PET: report of two cases Masahiro Kitada, Yoshinari Matuda, Satoshi Hayashi, Journal of Cardiothoracic Surgery	2013	42

Page 1